Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell Division Cycle 25A (CDC25A) is a dual-specificity phosphatase essential for cell cycle regulation, specifically the G1 to S phase transition and mitosis. It activates cyclin-dependent kinases (CDKs) by removing inhibitory phosphate groups. CDC25A overexpression is linked to various cancers, correlating with high-grade tumors and poor prognosis. It acts as an oncogene by promoting uncontrolled cell cycle progression. Its activity is tightly regulated by checkpoint kinases like Chk1 and Chk2.
Dephosphorylates and activates cyclin-dependent kinases (CDKs)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell Division Cycle 25 Homolog A (CDC25A).